Navigation Links

Biology Technology

PharmAthene Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards

ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its Board of Directors has adopted a stockholder rights plan (Rights Plan) in an effort to preserve the value of its net operating loss carryforwards (NOLs) under Section 382 of the Internal Revenue Code (Code). --> --> PharmAthene's use of its NOLs could be substantially lim... [Comments]

Une première dans l'identification des bactéries associées aux affections gingivales des félins

BRUSSELS , November 25, 2015 2 nouvelles études permettent d ' identifier pour la première fois les différences entre les souches bactériennes retrouvées dans la plaque dentaire des chats de celles des êtres humains . Ces recherches  ouvrent une nouvelle voie pour comprendre et envisager la prise en charge efficace de l'un de... [Comments]

New Research Reveals Bacteria Associated With Feline Gum Disease for the First Time

BRUSSELS , November 25, 2015 Studies reveal the differences in species of bacteria found in cat and human plaque and pave the way for more effective treatment for one of the most commonly diagnosed health problems in cats     --> --> Gum disease is one of the most commonly diagnosed health problems in cats, yet relatively little was understood about the bac... [Comments]

Bioengineered Organ Implant Company HART to Webcast LD Micro Presentation in Los Angeles, Tues. Dec. 1st at 2:30 pm PT

LOS ANGELES and HOLLISTON, Mass. , Nov. 25, 2015 Harvard Apparatus Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology company developing bioengineered organ implants for life-threatening conditions, today announced that CEO Jim McGorry will present at the LD Micro "Main Event" investor conference on Tuesday, December 1, 2015 at 2:30 p.m. PT. The presentation... [Comments]

Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference

SAN DIEGO , Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman , President and CEO of Neurocrine Biosciences, will be presenting at the 27th Annual Piper Jaffray Healthcare Conference in New York . .   Listeners are encouraged to visit the website approximately 5 minutes prior to the pr... [Comments]

Aeterna Zentaris Affirms Fundamental Strength of Business

QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) (the "Company"), affirms that its business and prospects remain fundamentally strong and highlights the following developments: Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to continue the ZoptEC Phase 3 clinical program to completion following review of th... [Comments]

Academy of Model Aeronautics and Organization of Black Aerospace Professionals Sign Collaborative Memorandum of Understanding

Muncie, IN (PRWEB) November 25, 2015 A long-standing partnership between the Academy of Model Aeronautics (AMA) and the Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a Memorandum of Understanding. AMA Executive Director Dave Mathewson and oth... [Comments]

Orexigen Therapeutics to Speak at the Piper Jaffray 27th Annual Healthcare Conference

SAN DIEGO , Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced that management will participate in a fireside chat discussion at the Piper Jaffray 27th Annual Healthcare Conference in New York . The discussion is scheduled for Wednesday, December 2, at 8:00 a.m. Eastern Time. .  A replay will be available for 14 days af... [Comments]

Global Genomics Industry: Key Growth Factors, Trends, Size, Demand and Opportunities

PORTLAND, Oregon , November 25, 2015 The Global Genomics Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Genomics industry.      (Logo: ) The report provides a basic overview of the industry including definitions, classifications, applicatio... [Comments]

New AngelList Syndicate Provides Opportunity for Investment in Early Stage Microbiome Companies

San Francisco, CA (PRWEB) November 25, 2015 Jessica Richman and Zachary Apte, founders of leading microbial genomics company uBiome, were featured on AngelList early in their initial angel funding process. Now, they are paying it forward to other microbiome startups by launching an AngelList... [Comments]

APAC's Volume Share and Margins in the Contract Research Organisation Market Set to Increase, Finds Frost & Sullivan

KUALA LUMPUR, Malaysia , Nov. 24, 2015  Asia-Pacific (APAC) holds the third-largest share of the global contract research organisation (CRO) market. The trend of outsourcing to low-cost locations is likely to result in lower margins but higher volume share for the region in the short term. With increased capacity and scale, however, margins in the CRO industry will improve... [Comments]

Medicine Technology

Amgen's First Biosimilar Biologics License Application For ABP 501 Submitted To U.S. Food And Drug Administration

THOUSAND OAKS, Calif. , Nov. 25, 2015  Amgen (NASDAQ: AMGN ) today announced the submission of a Biologics License Application (BLA) with the United States (U.S.) Food and Drug Administration (FDA) for ABP 501, a biosimilar candidate to Humira ® (adalimumab). Amgen believes this submission is the first adalimumab biosimilar application submitted to the FDA and r... [Comments]

Effort to Prevent, Treat Newborn Drug Exposure Becomes Law

WASHINGTON , Nov. 25, 2015  The American Academy of Pediatrics (AAP), American Congress of Obstetricians and Gynecologists (ACOG), and the March of Dimes cheered today's signature into law of the bipartisan Protecting Our Infants Act of 2015 (S.799), which takes much-needed strides to reduce the number of newborns born exposed to drugs, such as opioids, and to... [Comments]

Linden Care Responds To Court Ruling

WOODBURY, N.Y. , Nov. 25, 2015  Linden Care, LLC, a retail specialty pharmacy focused on medications access and optimizing treatment outcomes for patients suffering from chronic pain, said today that it is disappointed that its request for a Temporary Restraining Order (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy Provider Agreement between the... [Comments]

AAIPharma / Cambridge Major Laboratories to Invest $15M in Additional Laboratory Capacity and Global Headquarters in Wilmington, NC

WILMINGTON, N.C. , Nov. 25, 2015 AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAIPharma/CML) announces the planned investment of at least $15.8  Million to expand its laboratories and global headquarters in Wilmington, NC . The expansion will provide additional office space and development services capacity to meet the growing demands of the pharmaceuti... [Comments]

Pope McGlamry: $11 Million Verdict in First Wright Conserve Hip Bellwether Trial

ATLANTA , Nov. 25, 2015 On Tuesday, November 24, 2015, the jury in the first federal bellwether trial against Wright Medical Technology, Inc. for product liability and misrepresentation claims relating to their Conserve metal-on-metal hip implant device, awarded $11 million in favor of Plaintiff Robyn Christiansen.  Following a two week trial and three days of deliberatio... [Comments]

Accuracy of ARKRAY Blood Glucose Meters and Test Strips Demonstrated in Studies Presented at World Diabetes Congress

MINNEAPOLIS , Nov. 25, 2015  ARKRAY USA , Inc., a leader in diabetes care products, continues to provide evidence demonstrating the accuracy of its blood glucose meter systems. Last week at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease in Los Angeles , studies showed that both the Company's GLUCOCARD ® 01 meter and the Assure ... [Comments]

Henry Schein ConnectDental Pavilion At Greater New York Dental Meeting: The Next Step In Digital Dentistry

MELVILLE, N.Y. , Nov. 25, 2015  Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, will unveil at the Greater New York Dental (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion , which brings together for the first time the industry's broadest array of open solut... [Comments]

Kitov Pharmaceuticals Holdings Announces Closing of U.S. Initial Public Offering

TEL AVIV, Israel , November 25, 2015 Kitov Pharma ceuticals Holdings Ltd. (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company focused on the development of therapeutic candidates for the simultaneous treatment of various clinical conditions, today announced the closing of its previously announced underwritten public offering of 3,158,900 American Depository Shares (... [Comments]

Allergan Reaches Settlement with New York Attorney General's Office in Memantine Immediate Release Litigation

DUBLIN , Nov. 25, 2015 Allergan plc (NYSE: AGN ) today announced that it has reached an agreement with the New York State Attorney General's Office to end the litigation under Section 2 of the Sherman Act, and other statutes with the Attorney General over the decision of Forest Laboratories, Inc., announced in February 2014, to cease marketing and selling the now generic... [Comments]

Trovagene to Present at 27th Annual Piper Jaffray Healthcare Conference and Attend Evercore ISI Investor Conference

SAN DIEGO , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: TROV ), a developer of cell-free molecular diagnostics, today announced that Chief Executive Officer Antonius Schuh, Ph.D., is scheduled to present a corporate overview at the 27 th Annual Piper Jaffray Healthcare Conference. th Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York o... [Comments]

New Concept for Chronic Pain Treatment Patent Issued

SAN DIEGO , Nov. 25, 2015  Today AVACEN Medical announced the issue of United States patent No. 9,192,509  entitled: " Methods and Apparatus for Therapeutic Application of Thermal Energy Including Blood Viscosity Adjustment ". This patent shields the company's AVACEN 100 dry heat therapy medical device and specific methods of use, referred to by the company as the... [Comments]

(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), ... MultiGP, also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing ... AMA members have embraced this type of racing and several new model aviation pilots ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies would like ... to Deloitte's 2015 Technology Fast 500 list of the fastest growing companies in ... Class II medical device that speeds up orthodontic tooth movement by as much ...
(Date:11/24/2015)... INCLINE VILLAGE, Nev. , Nov. 24, 2015  PDL ... John P. McLaughlin , the company,s president and chief ... Piper Jaffray Healthcare Conference next week in New ... and will occur on Tuesday, December 1, 2015 at 9:30 ... and Presentations." Please connect to the website at least 15 ...
Breaking Biology Technology:
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Trovagene, ... molecular diagnostics, today announced that Chief Executive Officer Antonius ... at the 27 th Annual Piper Jaffray Healthcare ... Conference at the New York Palace Hotel in ... 2015 at 1:30 p.m. EST. Mr. Schuh will be ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ... and CEO, will discuss corporate updates at the 27 th ... York on Wednesday, December 2, 2015 at 1 ... Relations, and then the link to the event. Participants should ... to visit the site and download any streaming media software ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: